Cryopreservation and Validation of Microfragmented Adipose Tissue for Autologous Use in Knee Osteoarthritis Treatment
Authors:
- Marija ZekušićMarija Zekušić
- Petar BrlekPetar Brlek
- Lucija ZenićLZLucija Zenić
- Vilim MolnarVMVilim Molnar
- Maja LedinskiMLMaja Ledinski
- Marina Bujić MihicaMMMarina Bujić Mihica
- Adela ŠtimacAŠAdela Štimac
- Beata HalassyBHBeata Halassy
- Snježana RamićSRSnježana Ramić
- Dominik PuljićDPDominik Puljić
- Tiha VučemiloTVTiha Vučemilo
- Carlo TremoladaCTCarlo Tremolada
Open Access
- 20 July 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (14) , 6969
Abstract
Micro-fragmented adipose tissue (MFAT) is a promising autologous therapy for knee osteoarthritis. To avoid repeated liposuction procedures for its clinical application, MFAT obtained from patients with knee osteoarthritis was stored at −80 °C in a tissue bank. This study describes the preparation, cryopreservation, thawing, and washing, as well as comprehensive analysis of cell populations in fresh and MFAT thawed after two years. Immunophenotyping of both fresh and thawed MFAT showed a significant presence of endothelial progenitors and pericytes in the stromal vascular fraction. Viability before (59.75%) and after freezing (55.73%) showed no significant difference. However, the average cell count per gram of MFAT was significantly reduced in thawed samples (3.00 × 105) compared to fresh ones (5.64 × 105), likely due to processing steps. Thawed MFAT samples showed increased CD73 expression on the CD31highCD34high subset of EP and SA-ASC, as well as increased expression of CD105 on EP, the CD31lowCD34low subset of EP, pericytes, and SA-ASC. Microbiological testing confirmed 100% sterility, and double washing efficiently removed DMSO, confirming sample safety. Histological analysis revealed healthy, uniformly shaped adipocytes with intact membranes. This approach allows accurate estimation of cell yield for intra-articular injection, ensuring delivery of the target cell number into the knee. Quality control analysis confirms that cryopreserved MFAT retains high cellular and structural integrity, supporting its safety and suitability for clinical application.Keywords
Funding Information
- European Regional Development Fund (IRI 2—KK.01.2.1.02.0173)
- International Society for Applied Biological Sciences (ISABS) (IRI 2—KK.01.2.1.02.0173)
This publication has 34 references indexed in Scilit:
- Ice Inhibition for Cryopreservation: Materials, Strategies, and ChallengesAdvanced Science, 2021
- Long-Term Survival of Fat Transplants: Controlled DemonstrationsAesthetic Plastic Surgery, 2020
- Intraoperative Strategies for Minimal Manipulation of Autologous Adipose Tissue for Cell- and Tissue-Based Therapies: Concise ReviewStem Cells Translational Medicine, 2019
- Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclatureCytotherapy, 2019
- The addition of albumin improves Schwann cells viability in nerve cryopreservationCell and Tissue Banking, 2018
- Determination of residual dimethylsulfoxide in cryopreserved cardiovascular allograftsCell and Tissue Banking, 2017
- Adipose Tissue and Mesenchymal Stem Cells: State of the Art and Lipogems® Technology DevelopmentCurrent Stem Cell Reports, 2016
- Mesenchymal markers on human adipose stem/progenitor cellsCytometry Part A, 2012
- Pericytes: A universal adult tissue stem cell?Cytometry Part A, 2011
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human OrgansCell Stem Cell, 2008